This comprehensive investigation zeroed in on Klebsiella pneumoniae, a formidable member of the ESKAPE group of bacteria, which are known for their capacity to evade many frontline antimicrobials. K. pneumoniae is a familiar pathogen implicated in life-threatening infections, and alarming trends reveal its dissemination beyond human healthcare settings. Dr. Mauro Conter, an associate professor at the University of Parma’s Department of Veterinary Medical Sciences, led the examination of over 500 wildlife fecal samples collected from Northern Italy. These samples originated from species including red foxes, crows, magpies, and various water birds — animals that traverse urban, rural, and wilderness areas, forming conduits for the silent transmission of resistant bacteria.

The research highlights that wildlife, despite lack of direct antibiotic administration, can act as reservoirs for AMR bacteria and resistance genes. Foxes contribute to localized, ground-based spread, fragmenting resistance across short distances, whereas migratory birds can serve as vectors for long-range dissemination via natural flight patterns. This dual modality primes resistance genes for broader ecological infiltration, intertwining human, animal, and environmental health in a complex resistance matrix. Notably, Klebsiella species were isolated from 32 samples, with K. pneumoniae present in approximately 2% of all wildlife fecal specimens, signaling concerning environmental contamination by high-risk bacterial strains.

A particularly disturbing finding from the study was that K. pneumoniae isolates recovered from wildlife exhibited nearly complete resistance to third-generation cephalosporins—a stark contrast to clinical isolates. While clinical surveillance in Italy reports a 19.6% resistance rate to 3GCs among K. pneumoniae strains, this study revealed 100% resistance among wildlife isolates. This disparity not only underscores the wilderness as a reservoir of potent resistance but also foreshadows the insidious spread of these formidable pathogens into human populations, potentially undermining current therapeutic options.

Equally worrisome was the absolute resistance to fluoroquinolones observed in wildlife isolates. These antibiotics serve as critical tools to manage serious urinary tract infections and pneumonia. Human infections in Italy currently demonstrate a more moderate resistance percentage of 17.4%, highlighting a troubling escalation in resistance outside clinical surveillance and raising questions about environmental pressures selecting for multidrug-resistant phenotypes outside hospitals.

The genetic backbone for these alarming resistance profiles includes enzyme variants such as NDM-5 carbapenemase found in the isolated high-risk ST307 clone of K. pneumoniae. Carbapenemases degrade carbapenem antibiotics — often the last line of defense against resistant infections. The presence of such enzymes in wildlife signifies an unprecedented environmental dissemination of resistance mechanisms previously thought to be confined to clinical settings. This mechanism allows bacteria to circumvent even the most potent antimicrobial therapies, raising the stakes in global AMR management.

The study emphasizes that antibiotic resistance is not merely a clinical or hospital problem but rather an ecological challenge necessitating a ‘One Health’ approach. The interconnectedness of human, animal, and environmental health manifests through bacterial gene flow via water sources, waste management systems, and natural wildlife behavior. Surveillance of wildlife populations thus emerges as a valuable early warning system, capable of detecting emergent resistance patterns before they become widespread in clinical environments. Monitoring these environmental reservoirs could empower public health authorities to intervene proactively.

To stem the tide of resistance proliferation across ecosystems, the researchers advocate for multifaceted interventions. Reducing antibiotic pollution in wastewater streams, refining sewage treatment protocols, and encouraging judicious antimicrobial usage in agriculture and livestock are critical strategies. Furthermore, restricting the use of critically important antibiotics exclusively to human medicine could prevent environmental reservoirs from becoming breeding grounds for multidrug-resistant bacteria, including those harboring carbapenemases.

However, the authors caution that this study’s sampling methodology and scope impose limitations on fully extrapolating the data. The actual diversity and prevalence of resistant bacteria in the environment may be underestimated, and direct transmission chains between wildlife and humans remain to be conclusively established. Larger scale studies bridging human clinical isolates, animals, and environmental samples across national and international contexts will be vital to unravel the complexities of resistance transmission dynamics, although such endeavors are inherently challenging.

Emerging evidence also suggests that climate change and its impact on wildlife behavior could compound the spread of antimicrobial resistance. Shifts in migratory routes, altered habitats, and ecosystem disruptions may intensify interspecies bacterial exchanges, thereby accelerating the evolution and dissemination of resistant strains. Addressing AMR requires integrating these ecological factors into a holistic strategy that transcends traditional siloed approaches.

Ultimately, Dr. Conter’s team drove home the message that combating antimicrobial resistance demands coordinated, interdisciplinary solutions embracing microbiology, ecology, veterinary science, and public health. Their findings provide a compelling case for incorporating routine wildlife monitoring into global AMR surveillance systems. By doing so, policies can be better informed, interventions more timely, and resistance threats curtailed before overwhelming healthcare infrastructures worldwide.

The sobering reality of AMR spilling into the environment beyond clinics exposes the fragility of current antibiotic stewardship efforts. Only by recognizing wildlife as sentinels and reservoirs of resistance can we hope to anticipate and mitigate the relentless march of resistant pathogens. This study offers a clarion call to scientists, policymakers, and medical professionals alike: the war against antibiotic resistance is a battle that extends far beyond hospital walls into the very ecosystems where human and animal lives intersect.

Subject of Research: Animals

Article Title: Wildlife as sentinel of antimicrobial resistance in Klebsiella spp. with genomic insights into Klebsiella pneumoniae in Northern Italy

News Publication Date: 16-Apr-2026

Web References:
https://doi.org/10.3389/fmicb.2026.1716432

Keywords: Antimicrobial resistance, Klebsiella pneumoniae, third-generation cephalosporins, carbapenemase, wildlife reservoirs, environmental contamination, One Health, antibiotic stewardship, NDM-5, ESKAPE bacteria, fluoroquinolones, AMR surveillance

In this novel study, multidrug-resistant E. coli clones—previously identified in community and hospital-acquired infections worldwide—were found residing in the intestinal tracts of a barred owl (Strix hylophila) and a vulture. These birds were undergoing care at a rehabilitation center, a facility dedicated to rescuing and rehabilitating wild animals affected by environmental and anthropogenic stressors. The discovery highlights rehabilitation centers as potential hotspots for the interaction and dissemination of antibiotic-resistant bacteria beyond traditional clinical settings.

E. coli is a ubiquitous bacterium inhabiting the gastrointestinal tracts of humans and animals, typically harmless under normal circumstances. The bacteria become pathogenic when they invade sterile sites, such as the bloodstream, urinary tract, or kidneys. In compromised hosts, particularly immune-suppressed individuals, infections caused by multidrug-resistant E. coli often lead to severe illness and increased mortality rates. The alarming presence of these clones in wild birds represents an unforeseen reservoir and vector for spreading resistance genes.

The research underscores the urgent need to establish rigorous protocols for monitoring the microbial flora of animals within rehabilitation centers. Currently, these centers lack standardized, evidence-based procedures to detect, prevent, and manage colonization by antibiotic-resistant microorganisms. Given their role in mitigating human impact on wildlife, rehabilitation facilities must also prevent the inadvertent dissemination of resistant bacteria back into the wild, preserving both animal and public health.

Genomic analyses provided crucial insights into the genetic architecture of resistance in these bacterial clones. Resistance genes are often embedded within mobile genetic elements, such as plasmids and transposons, facilitating horizontal gene transfer across different bacterial strains and species in the environment. This mobility enables resistance determinants to propagate rapidly even in bacteria unexposed to direct antibiotic pressure, exemplifying the pervasive nature of resistance evolution.

One intriguing outcome of this phenomenon is the potential colonization of animals that have never been treated with or exposed to antibiotics, challenging the assumption that resistance is confined to polluted or hospital settings. Continuous environmental surveillance and pathogen monitoring across multiple hosts become paramount to timely detect and curb this silent spread of antimicrobial resistance (AMR).

The wild birds examined in this study were rescued from peri-urban regions—zones characterized by a blend of urban and rural landscapes. This ecological context increases wildlife exposure to anthropogenic contaminants such as sewage, garbage, and chemical pollutants, all of which exert selective pressure favoring resistant bacteria. The rehabilitation center in Santos provided an ideal sentinel environment to sample and assess the extent of AMR dissemination among diverse wild species.

Interestingly, no overt clinical infections were detected in the colonized birds, suggesting asymptomatic carriage of these high-risk clones. The vulture was confirmed to be colonized upon admission and was euthanized shortly thereafter due to severe injuries, eliminating questions about acquisition timing. Contrastingly, the owl had been resident for a decade, undergone multiple antibiotic treatments, and its exact point of bacterial acquisition—whether pre-admission or during rehabilitation—remained ambiguous.

This ambiguity presents a critical challenge for assessing biosecurity risks in wildlife care settings. It raises concerns about whether rehabilitation centers serve as reservoirs facilitating bacterial transmission among animals or from human caretakers. Consequently, more comprehensive studies and vigilance are imperative to dissect these dynamics and develop interventions that minimize the risk of AMR spread.

The researchers advocate for a proactive approach that includes screening animals upon admission to such facilities, isolating colonized individuals, and implementing decolonization therapies when medically warranted. Such strategies could mitigate the risk of releasing resistant bacteria into natural ecosystems, preserving ecological balance and preventing spillover to other wildlife or human populations.

Inspiring initiatives in Brazil, like the Costa Branca Cetacean Project led by the State University of Rio Grande do Norte, exemplify integrated pathogen surveillance in rescued marine species, including attempts to standardize probiotic-mediated decolonization prior to release. These efforts represent promising models for expanding epidemiological surveillance and antibiotic stewardship beyond clinical and agricultural contexts.

Overall, this landmark study illustrates the critical role that wildlife rehabilitation centers can play as sentinels for antibiotic resistance in natural environments. Interdisciplinary collaboration, global mobilization, and increased funding are essential to scale up research and implement robust containment protocols. By embracing One Health perspectives that integrate human, animal, and environmental health, the scientific community can better combat the multifaceted challenge posed by antimicrobial resistance.

This research not only advances our understanding of AMR reservoirs but also warns of the silent ecological circulation of multidrug-resistant pathogens. It calls for heightened awareness and strategic policies that address the complex interplay between human activities, wildlife health, and bacterial evolution. Such vigilance is key to safeguarding future generations from a post-antibiotic era where common infections could once again become lethal.

Subject of Research: Multidrug-resistant Escherichia coli clones in wild birds at rehabilitation centers and their implications for antimicrobial resistance spread.

Article Title: High-risk Escherichia coli global clones ST10 and ST155 in wild raptors admitted to a rehabilitation center

News Publication Date: 1-Jul-2025

Web References:

• Study published in Veterinary Research Communications: DOI 10.1007/s11259-025-10811-y
• One Health Brazilian Resistance platform: onehealthbr.com
• Costa Branca Cetacean Project: pccbuern.org

References:

• Sellera, F.P., Lincopan, N., et al. (2025). High-risk Escherichia coli global clones ST10 and ST155 in wild raptors admitted to a rehabilitation center. Veterinary Research Communications. DOI: 10.1007/s11259-025-10811-y.

Image Credits: Tamires Aparecida Serra Lorenzi/UNESP, São Vicente campus

Keywords: Drug resistance, Epidemiology, Public health, Animal diseases, Wild birds